Search Results
10
Everything
Search Filters
Organization
DelveInsight Business Research LLP
BALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight
March 04, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 04, 2025 (GLOBE NEWSWIRE) -- BALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight BALVERSA (erdafitinib) has strong market potential...
Global Operating Room Equipment Market is Predicted to Cross ~USD 40 Billion by 2032 | DelveInsight
March 04, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 04, 2025 (GLOBE NEWSWIRE) -- Global Operating Room Equipment Market is Predicted to Cross ~USD 40 Billion by 2032 | DelveInsight The operating room equipment market is...
Global Healthcare Mobility Solutions Market to Exhibit Tremendous Growth at a CAGR of ~21% by 2032 | DelveInsight
March 04, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 04, 2025 (GLOBE NEWSWIRE) -- Global Healthcare Mobility Solutions Market to Exhibit Tremendous Growth at a CAGR of ~21% by 2032 | DelveInsight The rising occurrence of chronic...
Dopamine Receptor Antagonists Clinical Trial Pipeline Analysis: 10+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | DelveInsight
March 04, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 04, 2025 (GLOBE NEWSWIRE) -- Dopamine Receptor Antagonists Clinical Trial Pipeline Analysis: 10+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics |...
Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight
March 04, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 04, 2025 (GLOBE NEWSWIRE) -- Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight The...
Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight
March 03, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight The microbial fermentation...
LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight
March 03, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight LEQEMBI (lecanemab) has significant...
Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
March 03, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment...
Global Artificial Intelligence in Drug Commercialization Market to Observe Stupendous Growth at a CAGR of ~24% by 2032 | DelveInsight
March 03, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- Global Artificial Intelligence in Drug Commercialization Market to Observe Stupendous Growth at a CAGR of ~24% by 2032 | DelveInsight The...
JAK Inhibitors Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
March 03, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- JAK Inhibitors Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight |...